supplemental 1 from Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma

Abstract

Patient clinical characteristics for the whole population and for the cohort with molecular analysis.